The ACF versus the pharmaceutical industry
The Anticancer Fund acknowledges the key role of pharmaceutical companies in cancer care, and stresses the importance of working together. The work of the ACF serves as a lever for the pharmaceutical industry.
Complementary pieces in a bigger puzzle
Decision-makers pressure the pharmaceutical industry to find solutions to all challenges. We acknowledge the economic reality of the for-profit domain, and recognise the need to fill gaps in the scope of available budgets and business plans.
This is why the parallel development of cancer treatments using public money is needed. The ACF supports this view, expresses this opinion, and applies funds to trials that fall outside of the scope of the pharmaceutical sector.
Individual companies & federations
Even though pharmaceutical companies wouldn't initiate the research trials we are involved in, they often agree to support them. On individual projects, we reach out to companies to use their products in trials with no strings attached and no influence whatsoever on study design or outcome. We always claim our independence and not-for-profit objectives.
We connect with European and international federations through conferences, meetings, roundtables and more.
Le Fonds Anticancer, un partenaire pour
NOTRE PROMESSE
-
Nous investissons dans la recherche scientifique la plus prometteuse pour réaliser des progrès certains dans la lutte contre le cancer. -
Améliorer et prolonger la vie des patients est notre seule cible. Le retour financier ne fait pas partie de nos objectifs. -
Nous identifions des potentiels inexploités dans la recherche sur le cancer qui amèneront des solutions pragmatiques pour les patients dans le besoin. -
Nous cherchons à obtenir un impact et pour ce faire, nous investissons nos ressources là où nous pensons pouvoir réaliser rapidement des progrès. -
Chaque cancer mérite la même attention, indépendamment de critères de prévalence ou de rentabilité.